speb/financial-data huggingface dataset:
Financial ratios for BALKRISIND.NS — quarterly report dated 2025-03-31
Total revenue: 321765256.02057517
Gross profit: 160599719.42950666
Operating income: 50886135.14145429
Net income: 43085106.38297872
Capital expenditures: 0
Depreciation & amortization: 20835866.261398174
Net tangible assets: 1213919803.6006546
Owner earnings: 63920972.6443769
Return on net tangible assets (%): 5.265666846753668
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 193317190
Book value: 1214355856.909048
Debt to equity: 0.3145529284916632
Current ratio: 1.318159771923391
Quick ratio: 0.8965658381933684
Effective tax rate (%): 24.033803978151088
Interest coverage ratio: 8.793535353535352
COGS to revenue (%): 50.08792390585602
SG&A to revenue (%): 26.23692949374723
Retained earnings: 516510404.4891279
Inventory turnover: 0.7736611426935963
Receivables turnover: 1.8416235095748528
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.8155646778009493
Revenue growth (%): 7.815169583628459
Rule of 40 score: 7.815169583628459
Financial ratios for BALKRISIND.NS — quarterly report dated 2025-06-30
Total revenue: 322960449.33302134
Gross profit: 166594898.19798738
Operating income: 37213901.240346365
Net income: 33735080.73952727
Capital expenditures: 0
Depreciation & amortization: 22018488.181605432
Owner earnings: 55753568.9211327
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 193317190
Effective tax rate (%): 26.897915715807088
Interest coverage ratio: 10.329002923026957
COGS to revenue (%): 48.41631582379837
Capitalized R&D asset: 0
Revenue growth (%): 0.3714488404458904
Rule of 40 score: 0.3714488404458904
Financial ratios for BALKRISIND.NS — quarterly report dated 2025-12-31
Total revenue: 304866882.0318592
Gross profit: 156704912.55430546
Operating income: 49871894.84237496
Net income: 42569900.85774758
Capital expenditures: 0
Depreciation & amortization: 21760053.469978835
Owner earnings: 64329954.32772641
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 193317190
Effective tax rate (%): 22.178552519040444
Interest coverage ratio: 13.148311306901615
COGS to revenue (%): 48.598906017633794
Capitalized R&D asset: 0
Revenue growth (%): -5.602409625862547
Rule of 40 score: -5.602409625862547
Financial ratios for CAMP — annual report dated 2022-12-31
Total revenue: 0
Operating income: -45001000
Net income: -44192000
Capital expenditures: 4025000
Operating cash flow: -38543000
Depreciation & amortization: 878000
Net tangible assets: -77531000
Owner earnings: -47339000
Buffett classification: The Gruesome
Shares outstanding: 51925800
Book value: -77531000
Debt to equity: -0.15987153525686498
Current ratio: 10.622829096400705
Quick ratio: 10.622829096400705
Free cash flow (dilution-adjusted): -43945000
Retained earnings: -110671000
Receivables turnover: 0
Capitalized R&D asset: 34771000
ROCI (R&D-adjusted, %): -16.866088497946524
Rule of 40 score: 0
Financial ratios for CAMP — annual report dated 2023-12-31
Total revenue: 350000
Operating income: -51879000
Net income: -49291000
Capital expenditures: 678000
Operating cash flow: -44155000
Depreciation & amortization: 1678000
Net tangible assets: -123730000
Owner earnings: -48291000
Buffett classification: The Gruesome
Shares outstanding: 51925800
Book value: -123730000
Debt to equity: -0.09450416228885476
Current ratio: 5.125272191622902
Quick ratio: 5.125272191622902
COGS to revenue (%): 0
R&D to revenue (%): 11604.571428571428
SG&A to revenue (%): 3318
Free cash flow (dilution-adjusted): -47740000
Retained earnings: -159962000
Receivables turnover: 0.7918552036199095
Capitalized R&D asset: 63912570
ROCI (R&D-adjusted, %): -32.77036065316321
FCF margin (%): -13640
Rule of 40 score: -13640
Financial ratios for CANHLIFE.NS — quarterly report dated 2024-12-31
Total revenue: 176760694.71966428
Net income: 3417647.744492365
Capital expenditures: 0
Owner earnings: 3417647.744492365
Buffett classification: The Gruesome
Shares outstanding: 947484925
Effective tax rate (%): -4.415954415954416
COGS to revenue (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CANHLIFE.NS — quarterly report dated 2025-03-31
Total revenue: 324581482.34743977
Net income: 3751461.304652794
Capital expenditures: 0
Net tangible assets: 175001169.0437222
Owner earnings: 3751461.304652794
Return on net tangible assets (%): 2.1436778537836685
Buffett classification: The Gruesome
Shares outstanding: 947484925
Book value: 177327566.05097008
Debt to equity: 0
Effective tax rate (%): 8.392806166143306
COGS to revenue (%): 0
Retained earnings: 51655365.910685055
Receivables turnover: 33.47160940325497
Capitalized R&D asset: 0
Revenue growth (%): 83.62763444792613
Rule of 40 score: 83.62763444792613
Financial ratios for CANHLIFE.NS — annual report dated 2025-03-31
Total revenue: 1224680851.0638297
Net income: 13675473.462707505
Capital expenditures: 1317512.2749590834
Depreciation & amortization: 2543839.1395838205
Net tangible assets: 175001169.0437222
Owner earnings: 14901800.327332241
Return on net tangible assets (%): 8.515257588713126
Buffett classification: The Gruesome
Shares outstanding: 947484925
Book value: 177327566.05097008
Debt to equity: 0
Effective tax rate (%): 8.71634802965275
COGS to revenue (%): 0
SG&A to revenue (%): 0.9434970866520554
Free cash flow (dilution-adjusted): 139849193.35983166
Retained earnings: 51655365.910685055
Receivables turnover: 126.29198312236286
Capitalized R&D asset: 0
FCF margin (%): 11.41923573299529
Rule of 40 score: 11.41923573299529
Financial ratios for CANHLIFE.NS — quarterly report dated 2025-06-30
Total revenue: 424948513.92464316
Net income: 2740463.374678212
Capital expenditures: 0
Owner earnings: 2740463.374678212
Buffett classification: The Gruesome
Shares outstanding: 947484925
Effective tax rate (%): 10.16494054468738
COGS to revenue (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 30.921983241720525
Rule of 40 score: 30.921983241720525
Financial ratios for GPTHEALTH.NS — annual report dated 2023-03-31
Total revenue: 43643982.94762485
Gross profit: 27341997.563946407
Operating income: 7332557.856272838
Net income: 4751230.207064556
Capital expenditures: 1033532.2777101097
Operating cash flow: 8082277.710109623
Depreciation & amortization: 1816358.0998781975
Net tangible assets: 20093897.685749087
Owner earnings: 5534056.029232644
Return on net tangible assets (%): 27.54097843922777
Capex to operating income (%): 14.09511248282816
Buffett classification: The Great
Shares outstanding: 82054823
Book value: 20141595.61510353
Debt to equity: 0.4980343185425959
Current ratio: 0.9929732860242801
Quick ratio: 0.8839767462318925
Effective tax rate (%): 30.305488356137467
Interest coverage ratio: 7.130371440754251
COGS to revenue (%): 37.35219446685632
SG&A to revenue (%): 2.231933669925326
Free cash flow (dilution-adjusted): 6870767.356881852
Retained earnings: 5332216.808769793
Inventory turnover: 15.003060263653484
Receivables turnover: 17.329594807656964
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.580299600510877
FCF margin (%): 15.742759695253172
Rule of 40 score: 15.742759695253172
Financial ratios for IKIO.NS — annual report dated 2023-03-31
Total revenue: 43698538.3678441
Gross profit: 15520462.850182705
Operating income: 9003532.27771011
Net income: 6094762.484774666
Capital expenditures: 2363093.7880633376
Operating cash flow: 6920097.442143728
Depreciation & amortization: 704872.1071863582
Net tangible assets: 17245432.39951279
Owner earnings: 4436540.803897686
Return on net tangible assets (%): 25.725889041918283
Capex to operating income (%): 26.24629662197811
Buffett classification: The Good
Shares outstanding: 77280701
Book value: 17315590.742996346
Debt to equity: 0.8634998346944662
Current ratio: 1.3577102581198208
Quick ratio: 0.5917579452011302
Effective tax rate (%): 23.983289023927078
Interest coverage ratio: 16.864932694501483
COGS to revenue (%): 64.48287876465095
R&D to revenue (%): 0.2611737488328014
SG&A to revenue (%): 1.414296266358201
Free cash flow (dilution-adjusted): 4526674.786845311
Retained earnings: 7464555.420219245
Inventory turnover: 1.9178452406612172
Receivables turnover: 4.935955643607947
Capitalized R&D asset: 179688.9156670243
ROCI (R&D-adjusted, %): 47.93500181946487
FCF margin (%): 10.358870012403662
Rule of 40 score: 10.358870012403662
Financial ratios for LB — annual report dated 2022-12-31
Total revenue: 51777000
Gross profit: 41217000
Operating income: -3232000
Net income: -6361000
Capital expenditures: 3291000
Operating cash flow: 20500000
Depreciation & amortization: 6720000
Net tangible assets: 179081000
Owner earnings: -2932000
Return on net tangible assets (%): -1.6372479492520144
Buffett classification: The Gruesome
Shares outstanding: 27839229
Book value: 209959000
Debt to equity: 0.27438690410985
Current ratio: 2.17045785095119
Quick ratio: 2.17045785095119
Interest coverage ratio: -1.03989703989704
COGS to revenue (%): 20.395156150414277
SG&A to revenue (%): 80.73275778820712
Free cash flow (dilution-adjusted): -19151000
Receivables turnover: 4.571113269179836
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2486912309576519
FCF margin (%): -36.987465476949225
Rule of 40 score: -36.987465476949225
Financial ratios for LB — annual report dated 2023-12-31
Total revenue: 72865000
Gross profit: 60658000
Operating income: 70009000
Net income: 63172000
Capital expenditures: 2783000
Operating cash flow: 53042000
Depreciation & amortization: 8825000
Net tangible assets: 122104000
Owner earnings: 69214000
Return on net tangible assets (%): 56.68446570136933
Capex to operating income (%): 3.975203188161522
Buffett classification: The Great
Shares outstanding: 27839229
Book value: 150747000
Debt to equity: 0.8536289279388645
Current ratio: 1.9290774907749078
Quick ratio: 1.9290774907749078
Effective tax rate (%): 0.5822920273205124
Interest coverage ratio: 9.978477765108323
COGS to revenue (%): 16.752899197145407
SG&A to revenue (%): -16.593700679338504
Free cash flow (dilution-adjusted): 67489000
Receivables turnover: 5.429582712369598
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.736401513849582
FCF margin (%): 92.62197214025937
Revenue growth (%): 40.72850879734245
Rule of 40 score: 133.35048093760182
Financial ratios for SUNC — annual report dated 2023-12-31
Total revenue: 23068000000
Gross profit: 1178000000
Operating income: 628000000
Net income: 0
Capital expenditures: 31000000
Operating cash flow: 600000000
Depreciation & amortization: 187000000
Owner earnings: 156000000
Capex to operating income (%): 4.936305732484077
Buffett classification: The Great
Shares outstanding: 51517198
Effective tax rate (%): 8.372093023255815
Interest coverage ratio: 2.8940092165898617
COGS to revenue (%): 94.89335876538928
SG&A to revenue (%): 0.8409918501820703
Free cash flow (dilution-adjusted): 368000000
Capitalized R&D asset: 0
FCF margin (%): 1.5952835096237212
Rule of 40 score: 1.5952835096237212
Financial ratios for SUNC — annual report dated 2024-12-31
Total revenue: 22693000000
Gross profit: 1730000000
Operating income: 836000000
Net income: 0
Capital expenditures: 23000000
Operating cash flow: 549000000
Depreciation & amortization: 363000000
Net tangible assets: 2044000000
Owner earnings: 340000000
Return on net tangible assets (%): 16.634050880626223
Capex to operating income (%): 2.751196172248804
Buffett classification: The Great
Shares outstanding: 51517198
Book value: 4068000000
Debt to equity: 1.966322517207473
Current ratio: 1.266050333846944
Quick ratio: 0.7175141242937854
Effective tax rate (%): 16.682554814108673
Interest coverage ratio: 2.1381074168797953
COGS to revenue (%): 92.37650376768165
SG&A to revenue (%): 1.537919182126647
Free cash flow (dilution-adjusted): 188000000
Inventory turnover: 19.628277153558052
Receivables turnover: 19.529259896729776
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.726746057289991
FCF margin (%): 0.8284493015467324
Revenue growth (%): -1.625628576382868
Rule of 40 score: -0.7971792748361356
Financial ratios for SUNC — quarterly report dated 2025-03-31
Capital expenditures: 3000000
Operating cash flow: 156000000
Depreciation & amortization: 156000000
Buffett classification: The Gruesome
Shares outstanding: 51517198
Free cash flow (dilution-adjusted): 51000000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 0901.HK — annual report dated 2022-12-31
Total revenue: 363396839.0804598
Gross profit: 68566954.02298851
Operating income: 35297701.14942529
Net income: 36042528.73563218
Capital expenditures: 1156321.8390804597
Operating cash flow: 8353879.310344827
Depreciation & amortization: 2260632.1839080458
Net tangible assets: 100044971.26436782
Owner earnings: 37146839.080459766
Return on net tangible assets (%): 37.130141186506634
Capex to operating income (%): 3.2759125989123707
Buffett classification: The Great
Shares outstanding: 209393562
Book value: 101897413.79310344
Debt to equity: 0.21297479152742643
Current ratio: 1.8596590975318827
Quick ratio: 1.4046173751209323
Effective tax rate (%): 10.55360237329473
Interest coverage ratio: 27.64708530272339
COGS to revenue (%): 81.1316592085692
R&D to revenue (%): 3.813276863186678
SG&A to revenue (%): 2.8055441116350273
Free cash flow (dilution-adjusted): 6649281.609195402
Retained earnings: 46868821.83908046
Inventory turnover: 5.8403756937526685
Receivables turnover: 3.7503365934958866
Capitalized R&D asset: 13857327.586206896
ROCI (R&D-adjusted, %): 38.34947672641928
FCF margin (%): 1.8297576902486987
Rule of 40 score: 1.8297576902486987
Financial ratios for 0901.HK — annual report dated 2023-12-31
Total revenue: 332893108.2981716
Gross profit: 70389310.82981716
Operating income: 26260337.552742615
Net income: 26892967.651195496
Capital expenditures: 1251617.4402250352
Operating cash flow: 4032348.8045007032
Depreciation & amortization: 2678762.306610408
Net tangible assets: 125607454.28973277
Owner earnings: 28320112.51758087
Return on net tangible assets (%): 22.546522161221585
Capex to operating income (%): 4.766189458575018
Buffett classification: The Great
Shares outstanding: 209393562
Book value: 126638818.56540084
Debt to equity: 0.1364379466060715
Current ratio: 1.8822760490896409
Quick ratio: 1.3409026914396365
Effective tax rate (%): 4.51056476945281
Interest coverage ratio: 53.16372437357631
COGS to revenue (%): 78.85528144765027
R&D to revenue (%): 6.304909014859287
SG&A to revenue (%): 3.6390676294008544
Free cash flow (dilution-adjusted): -2221378.3403656823
Retained earnings: 70065260.19690576
Inventory turnover: 3.7336328664963623
Receivables turnover: 3.064155310846955
Capitalized R&D asset: 30273017.077695325
ROCI (R&D-adjusted, %): 22.689220733789103
Rosenberg metric: 0.1315085318934481
FCF margin (%): -0.6672947817159371
Revenue growth (%): -8.394055066487343
Rule of 40 score: -9.06134984820328
Financial ratios for 0901.HK — annual report dated 2024-12-31
Total revenue: 348073424.65753424
Gross profit: 66156986.30136987
Operating income: 16116849.315068493
Net income: 18798356.16438356
Capital expenditures: 1854931.506849315
Operating cash flow: 17240273.97260274
Depreciation & amortization: 2380684.9315068494
Net tangible assets: 141093561.64383563
Owner earnings: 19324109.589041095
Return on net tangible assets (%): 13.695954205069402
Capex to operating income (%): 11.509268781926513
Buffett classification: The Great
Shares outstanding: 209393562
Book value: 142062054.79452053
Debt to equity: 0.21931858834601514
Current ratio: 1.7999726112625194
Quick ratio: 1.2547321651980443
Effective tax rate (%): 2.738677439931958
Interest coverage ratio: 19.22120568534553
COGS to revenue (%): 80.99338196633053
R&D to revenue (%): 6.324677205565194
SG&A to revenue (%): 3.749877997714228
Free cash flow (dilution-adjusted): 14753835.616438355
Retained earnings: 84511232.87671234
Inventory turnover: 3.190672276985188
Receivables turnover: 3.099541583209113
Capitalized R&D asset: 40649805.740001075
ROCI (R&D-adjusted, %): 10.459099391959297
Rosenberg metric: -0.2016486567440662
FCF margin (%): 4.238713607898821
Revenue growth (%): 4.560117341259492
Rule of 40 score: 8.798830949158312
Financial ratios for 0901.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 141093561.64383563
Buffett classification: The Gruesome
Shares outstanding: 209393562
Book value: 142062054.79452053
Debt to equity: 0.21931858834601514
Current ratio: 1.7999726112625194
Quick ratio: 1.2547321651980443
Retained earnings: 84511232.87671234
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 0901.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 156773082.28730822
Buffett classification: The Gruesome
Shares outstanding: 209393562
Book value: 157808089.26080894
Debt to equity: 0.1566915661202456
Current ratio: 1.8839090077111964
Quick ratio: 1.3985812626711054
Retained earnings: 99544072.52440725
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2549.HK — annual report dated 2022-12-31
Total revenue: 110414080.45977011
Gross profit: 39553160.91954023
Operating income: 18205890.804597702
Net income: 15627873.56321839
Capital expenditures: 16552298.850574713
Operating cash flow: 18484051.724137932
Depreciation & amortization: 630316.091954023
Net tangible assets: 11726436.781609196
Owner earnings: -294109.1954023
Return on net tangible assets (%): -2.5080866496765433
Capex to operating income (%): 90.91726973554411
Buffett classification: The Gruesome
Shares outstanding: 550801100
Book value: 19720258.62068966
Debt to equity: 0.42780849963206624
Current ratio: 0.781253392143729
Quick ratio: 0.669604538919968
Effective tax rate (%): 14.204824041122974
Interest coverage ratio: 60.28211227402473
COGS to revenue (%): 64.17847132398677
R&D to revenue (%): 2.7094974247932937
SG&A to revenue (%): 14.483097847444704
Free cash flow (dilution-adjusted): 1616810.3448275863
Retained earnings: 13072557.471264368
Inventory turnover: 11.695240805292736
Receivables turnover: 13.894841520964796
Capitalized R&D asset: 2991666.6666666665
ROCI (R&D-adjusted, %): 71.65831638642682
FCF margin (%): 1.4643153645758782
Rule of 40 score: 1.4643153645758782
Financial ratios for 2549.HK — annual report dated 2023-12-31
Total revenue: 222655696.20253164
Gross profit: 79485372.71448663
Operating income: 35923206.75105485
Net income: 33351898.734177213
Capital expenditures: 824613.2208157524
Operating cash flow: 34310970.46413502
Depreciation & amortization: 638959.2123769339
Net tangible assets: 31317018.28410689
Owner earnings: 33166244.725738395
Return on net tangible assets (%): 105.9048611360615
Capex to operating income (%): 2.2954888925430867
Buffett classification: The Great
Shares outstanding: 550801100
Book value: 31310970.46413502
Debt to equity: 0.043890738070532426
Current ratio: 1.2920932608457694
Quick ratio: 1.0287006969022512
Effective tax rate (%): 15.033074272491762
Interest coverage ratio: 859.979797979798
COGS to revenue (%): 64.30121749852503
R&D to revenue (%): 2.266780874269305
SG&A to revenue (%): 17.499788387461926
Free cash flow (dilution-adjusted): 33486357.243319266
Retained earnings: 46148663.85372714
Inventory turnover: 9.40083301010325
Receivables turnover: 21.435291250304655
Capitalized R&D asset: 7051533.403656822
ROCI (R&D-adjusted, %): 98.9671250620365
Rosenberg metric: 13.347814527558686
FCF margin (%): 15.039524168678565
Revenue growth (%): 101.6551650617217
Rule of 40 score: 116.69468923040027
Financial ratios for 505A.T — annual report dated 2024-05-31
Total revenue: 37213934.37400446
Gross profit: 32499764.25613253
Operating income: 7645479.452054795
Net income: 5452156.737814591
Capital expenditures: 0
Operating cash flow: 6776884.358075821
Depreciation & amortization: 530780.5033450144
Net tangible assets: 13076553.042370183
Owner earnings: 5982937.241159606
Return on net tangible assets (%): 45.75316768703422
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 11231000
Book value: 13721586.492513541
Debt to equity: 0
Current ratio: 2.240227139182954
Quick ratio: 2.240227139182954
Effective tax rate (%): 28.515733011213218
COGS to revenue (%): 12.667755229785607
SG&A to revenue (%): 66.78757627261128
Free cash flow (dilution-adjusted): 5142503.982159924
Retained earnings: 22488518.636508442
Receivables turnover: 11.43527539137449
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 55.391923113319685
FCF margin (%): 13.818759205831741
Rule of 40 score: 13.818759205831741
Financial ratios for 505A.T — annual report dated 2025-05-31
Total revenue: 49714605.64751704
Gross profit: 44437592.15468076
Operating income: 4895347.058005285
Net income: 3433426.0676032826
Capital expenditures: 36757.546251217136
Operating cash flow: 4933732.090694116
Depreciation & amortization: 820858.2556683823
Net tangible assets: 17220121.018222284
Owner earnings: 4217526.777020448
Return on net tangible assets (%): 24.491853295092834
Capex to operating income (%): 0.7508670134246782
Buffett classification: The Great
Shares outstanding: 11231000
Book value: 17633356.516900823
Debt to equity: 0
Current ratio: 2.0253652670034383
Quick ratio: 2.0253652670034383
Effective tax rate (%): 30.172906423451
COGS to revenue (%): 10.61461400348015
SG&A to revenue (%): 79.53848689263492
Free cash flow (dilution-adjusted): 2264953.4010293502
Retained earnings: 27053790.513284184
Receivables turnover: 12.393633234791805
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 26.712662017287915
FCF margin (%): 4.555911429908872
Revenue growth (%): 33.5913723818593
Rule of 40 score: 38.147283811768176
Financial ratios for 5727.T — annual report dated 2022-03-31
Total revenue: 454966398.95099163
Gross profit: 112768398.62317653
Operating income: 42853630.55236846
Net income: 30314702.50778561
Capital expenditures: 85436813.63710867
Operating cash flow: 80232748.72971645
Depreciation & amortization: 49623012.620881826
Net tangible assets: 375151614.489428
Owner earnings: -5499098.508441225
Return on net tangible assets (%): -1.465833624606777
Capex to operating income (%): 199.3689041881813
Buffett classification: The Gruesome
Shares outstanding: 71186097
Book value: 386543189.6410424
Debt to equity: 0.8571428571428573
Current ratio: 1.6631664246885234
Quick ratio: 0.4748286457102339
Effective tax rate (%): 25.821972734562955
Interest coverage ratio: 29.879999999999995
COGS to revenue (%): 75.21390615149059
Free cash flow (dilution-adjusted): -6507129.9786920175
Retained earnings: 183486313.71906245
Inventory turnover: 1.186390112231851
Receivables turnover: 5.369474804139665
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.636029089634626
FCF margin (%): -1.4302440781770693
Rule of 40 score: -1.4302440781770693
Financial ratios for 5727.T — annual report dated 2023-03-31
Total revenue: 603235735.7357358
Gross profit: 160082582.5825826
Operating income: 80285285.2852853
Net income: 56343843.84384385
Capital expenditures: 48453453.45345346
Operating cash flow: 39744744.74474475
Depreciation & amortization: 51103603.60360361
Net tangible assets: 391276276.2762763
Owner earnings: 58993993.99399399
Return on net tangible assets (%): 15.077324532790973
Capex to operating income (%): 60.35159902749206
Buffett classification: The Good
Shares outstanding: 71186097
Book value: 400000000.00000006
Debt to equity: 0.8369932432432431
Current ratio: 1.8437582321088832
Quick ratio: 0.6086931069808285
Effective tax rate (%): 27.64870336450401
Interest coverage ratio: 61.45977011494253
COGS to revenue (%): 73.46143794103371
Free cash flow (dilution-adjusted): -9024024.024024025
Retained earnings: 213731231.23123124
Inventory turnover: 1.398876670774481
Receivables turnover: 5.238688225322727
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.840857320356182
FCF margin (%): -1.4959365782628715
Revenue growth (%): 32.589074078131105
Rule of 40 score: 31.093137499868234
Financial ratios for 5727.T — annual report dated 2024-03-31
Total revenue: 517723190.7025885
Gross profit: 101135763.33861595
Operating income: 37169836.238774434
Net income: 32712625.462229267
Capital expenditures: 53466719.49286846
Operating cash flow: -20701267.828843106
Depreciation & amortization: 48844426.83571051
Net tangible assets: 367947702.06022185
Owner earnings: 28090332.805071317
Return on net tangible assets (%): 7.634327554646281
Capex to operating income (%): 143.84437733167522
Buffett classification: The Gruesome
Shares outstanding: 71186097
Book value: 373402007.3956682
Debt to equity: 0.9925549975242274
Current ratio: 1.5915069759623468
Quick ratio: 0.4868885526979325
Effective tax rate (%): 19.977390180878555
Interest coverage ratio: 25.703196347031966
COGS to revenue (%): 80.46528238355187
Free cash flow (dilution-adjusted): -74564183.83518225
Retained earnings: 208940834.6539884
Inventory turnover: 1.2000532613037607
Receivables turnover: 4.181100682593857
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.1789312587680145
FCF margin (%): -14.402326411917759
Revenue growth (%): -14.175643113856973
Rule of 40 score: -28.577969525774733
Financial ratios for 5727.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 388639865.52738476
Buffett classification: The Gruesome
Shares outstanding: 71186097
Book value: 393563524.3031237
Debt to equity: 0.9379460075098321
Current ratio: 1.5878110265627188
Quick ratio: 0.47222351897670517
Retained earnings: 219540551.89802495
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 5727.T — annual report dated 2025-03-31
Total revenue: 594666488.4373747
Gross profit: 107285122.30985162
Operating income: 39299558.88250234
Net income: 24903087.822483625
Capital expenditures: 81646838.65793343
Operating cash flow: 128879828.8998797
Depreciation & amortization: 50481219.08835717
Net tangible assets: 385296083.41130865
Owner earnings: -6262531.747092634
Return on net tangible assets (%): -1.625381626422426
Capex to operating income (%): 207.75510204081633
Buffett classification: The Gruesome
Shares outstanding: 71186097
Book value: 389860981.1522524
Debt to equity: 0.9093278016834958
Current ratio: 1.594307270233196
Quick ratio: 0.5240969364426152
Effective tax rate (%): 30.133133320832556
Interest coverage ratio: 17.872340425531917
COGS to revenue (%): 81.95765054959875
Free cash flow (dilution-adjusted): 46090094.90709798
Retained earnings: 224020852.82716215
Inventory turnover: 1.557774881972186
Receivables turnover: 6.10246913580247
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.255676209279368
FCF margin (%): 7.750578820779104
Revenue growth (%): 14.861860375690044
Rule of 40 score: 22.612439196469147
Financial ratios for 5727.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 385296083.41130865
Buffett classification: The Gruesome
Shares outstanding: 71186097
Book value: 389860981.1522524
Debt to equity: 0.9093278016834958
Current ratio: 1.594307270233196
Quick ratio: 0.5240969364426152
Retained earnings: 224020852.82716215
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 6224.T — annual report dated 2022-02-28
Total revenue: 69957198.4772452
Gross profit: 22854101.05554594
Operating income: 7412450.250908461
Net income: 4718515.314068178
Capital expenditures: 1038743.7272884583
Operating cash flow: 8840474.1304724
Depreciation & amortization: 2373870.911922478
Net tangible assets: 23081718.290361654
Owner earnings: 6053642.498702197
Return on net tangible assets (%): 26.22700105143405
Capex to operating income (%): 14.01350015349042
Buffett classification: The Great
Shares outstanding: 12919737
Book value: 23574355.42481398
Debt to equity: 1.5223560257846303
Current ratio: 2.1727479968886847
Quick ratio: 1.7377837348527465
Effective tax rate (%): 34.98577203546322
Interest coverage ratio: 31.86176503402878
COGS to revenue (%): 67.33129655700041
Free cash flow (dilution-adjusted): 7302543.692680394
Retained earnings: 23867485.724173732
Inventory turnover: 5.614531102718691
Receivables turnover: 4.563171828343783
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.782792450442921
FCF margin (%): 10.43858795325498
Rule of 40 score: 10.43858795325498
Financial ratios for 6224.T — annual report dated 2023-02-28
Total revenue: 65736245.59859155
Gross profit: 22178484.448356807
Operating income: 9186671.068075119
Net income: 6095466.549295775
Capital expenditures: 722417.8403755869
Operating cash flow: 7560357.981220658
Depreciation & amortization: 1714583.3333333335
Net tangible assets: 24941960.093896713
Owner earnings: 7087632.04225352
Return on net tangible assets (%): 28.416499808240253
Capex to operating income (%): 7.8637608228521785
Buffett classification: The Great
Shares outstanding: 12919737
Book value: 25308707.45305165
Debt to equity: 1.0788146256191515
Current ratio: 2.001380096222627
Quick ratio: 1.6237334096159957
Effective tax rate (%): 34.593138582250745
Interest coverage ratio: 51.07369494290376
COGS to revenue (%): 66.26139570022424
Free cash flow (dilution-adjusted): 6779063.96713615
Retained earnings: 25598136.7370892
Inventory turnover: 5.297717476742495
Receivables turnover: 4.64250615077998
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.90475299965701
FCF margin (%): 10.312520749255258
Revenue growth (%): -6.033621943889854
Rule of 40 score: 4.278898805365404
Financial ratios for 9564.T — annual report dated 2022-09-30
Total revenue: 25986311.708093885
Gross profit: 17622668.420688223
Operating income: 3144229.0382884443
Net income: 2071522.5368690714
Capital expenditures: 180703.45496088068
Operating cash flow: 1251222.0452814512
Depreciation & amortization: 322107.5953749221
Net tangible assets: 5306224.468600706
Owner earnings: 2212926.677283113
Return on net tangible assets (%): 41.704354770100394
Capex to operating income (%): 5.7471466855749895
Buffett classification: The Great
Shares outstanding: 22073732
Book value: 5559551.339749359
Debt to equity: 0.4464996027229049
Current ratio: 1.8421744467636931
Quick ratio: 1.8084457797371978
Effective tax rate (%): 34.221183526659686
Interest coverage ratio: 555.8396572827418
COGS to revenue (%): 32.18480322007629
Free cash flow (dilution-adjusted): 859800.5954441598
Retained earnings: 7415142.283459115
Inventory turnover: 34.2130738946951
Receivables turnover: 15.669292686388953
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 38.093596360766
FCF margin (%): 3.308667290311768
Rule of 40 score: 3.308667290311768
Financial ratios for BA.TO — annual report dated 2022-12-31
Total revenue: 48976470588.23529
Gross profit: 2595588235.2941175
Operating income: -2580147058.8235292
Net income: -3628676470.588235
Capital expenditures: 872794117.6470587
Operating cash flow: 2582352941.1764703
Depreciation & amortization: 1455147058.8235292
Net tangible assets: -19302205882.35294
Owner earnings: -3046323529.411764
Buffett classification: The Gruesome
Shares outstanding: 6214434086
Book value: -11652941176.470581
Debt to equity: -3.614146895507322
Current ratio: 1.2162195176120465
Quick ratio: 0.3483764935814863
Interest coverage ratio: -1.370167903162827
COGS to revenue (%): 94.70033629594042
R&D to revenue (%): 4.281767955801105
SG&A to revenue (%): 6.286031707902954
Free cash flow (dilution-adjusted): 1150735294.117647
Retained earnings: 21671323529.411762
Inventory turnover: 0.8071297872068175
Receivables turnover: 5.8919062361786825
Capitalized R&D asset: 2097058823.5294116
ROCI (R&D-adjusted, %): -3.2217768871075485
FCF margin (%): 2.3495676195051645
Rule of 40 score: 2.3495676195051645
Financial ratios for BA.TO — annual report dated 2023-12-31
Total revenue: 58934848484.84848
Gross profit: 5851515151.515151
Operating income: -621969696.969697
Net income: -1683333333.3333333
Capital expenditures: 1136363636.3636363
Operating cash flow: 4515151515.151515
Depreciation & amortization: 1409848484.8484848
Net tangible assets: -20772727272.727272
Owner earnings: -1409848484.8484848
Buffett classification: The Gruesome
Shares outstanding: 6214434086
Book value: -13051515151.515152
Debt to equity: -3.053343394474112
Current ratio: 1.1403362309161302
Quick ratio: 0.30820123764700985
Interest coverage ratio: -0.3338755591703945
COGS to revenue (%): 90.07121371828161
R&D to revenue (%): 4.3409517443504635
SG&A to revenue (%): 6.643185849808468
Free cash flow (dilution-adjusted): 2835606060.6060605
Retained earnings: 20644696969.696968
Inventory turnover: 0.8787198555322857
Receivables turnover: 7.030637144148215
Capitalized R&D asset: 3963362745.0980387
ROCI (R&D-adjusted, %): 1.0936325073220656
Rosenberg metric: 1.5526159207786137
FCF margin (%): 4.81142504563334
Revenue growth (%): 20.33298393495367
Rule of 40 score: 25.14440898058701
Financial ratios for BA.TO — annual report dated 2024-12-31
Total revenue: 46515384615.38462
Gross profit: -1392307692.3076923
Operating income: -7569230769.230769
Net income: -8263636363.636364
Capital expenditures: 1525174825.1748252
Operating cash flow: -8447552447.552448
Depreciation & amortization: 1283916083.916084
Net tangible assets: -9754545454.545454
Owner earnings: -8504895104.895105
Buffett classification: The Gruesome
Shares outstanding: 6214434086
Book value: -2737062937.0629425
Debt to equity: -13.844660194174732
Current ratio: 1.318506767753765
Quick ratio: 0.4166546488390778
Interest coverage ratio: -3.972110091743119
COGS to revenue (%): 102.9932197784025
R&D to revenue (%): 5.730865793706871
SG&A to revenue (%): 7.548446261857871
Free cash flow (dilution-adjusted): -10353146853.146854
Retained earnings: 10742657342.657343
Inventory turnover: 0.7825014277555682
Receivables turnover: 5.938487635032587
Capitalized R&D asset: 5071847010.832305
ROCI (R&D-adjusted, %): -15.783128093445745
Rosenberg metric: -2.8314616979112097
FCF margin (%): -22.25746801569524
Revenue growth (%): -21.07320912627233
Rule of 40 score: -43.33067714196757
Financial ratios for BA.TO — quarterly report dated 2025-03-31
Total revenue: 13633566433.566435
Gross profit: 1690209790.2097902
Operating income: 322377622.37762237
Net income: -21678321.67832168
Capital expenditures: 469230769.2307693
Operating cash flow: -1130069930.06993
Depreciation & amortization: 325874125.8741259
Net tangible assets: -9314685314.685314
Owner earnings: -165034965.03496504
Capex to operating income (%): 145.5531453362256
Buffett classification: The Gruesome
Shares outstanding: 6214434086
Book value: -2325174825.17482
Debt to equity: -16.125714285714324
Current ratio: 1.2316167248731358
Quick ratio: 0.37224805603257005
Effective tax rate (%): 140.78947368421052
Interest coverage ratio: 0.6511299435028248
COGS to revenue (%): 87.6025851456709
R&D to revenue (%): 4.329093147312269
SG&A to revenue (%): 5.70373409930242
Free cash flow (dilution-adjusted): -1695804195.804196
Retained earnings: 10656643356.643356
Inventory turnover: 0.19173299504922708
Receivables turnover: 1.567580606255528
Capitalized R&D asset: 590209790.2097902
ROCI (R&D-adjusted, %): 1.9068375431537634
FCF margin (%): -12.438448912597455
Rule of 40 score: -12.438448912597455
Financial ratios for BA.TO — quarterly report dated 2025-06-30
Total revenue: 16605109489.051094
Gross profit: 1777372262.7737224
Operating income: -195620437.95620435
Net income: -445985401.459854
Capital expenditures: 310948905.109489
Operating cash flow: 165693430.6569343
Depreciation & amortization: 335766423.3576642
Net tangible assets: -8844525547.445255
Owner earnings: -421167883.2116788
Buffett classification: The Gruesome
Shares outstanding: 6214434086
Book value: -2405839416.05838
Debt to equity: -16.17809466019427
Current ratio: 1.2314366971057114
Quick ratio: 0.38159727596347315
Interest coverage ratio: -0.37746478873239436
COGS to revenue (%): 89.29623280144182
R&D to revenue (%): 4.000175831904699
SG&A to revenue (%): 7.8816651281375005
Free cash flow (dilution-adjusted): -232846715.32846713
Retained earnings: 10614598540.145985
Inventory turnover: 0.23122716355730594
Receivables turnover: 1.8247373064891312
Capitalized R&D asset: 1059674136.0828953
ROCI (R&D-adjusted, %): 0.12996813561666473
Rosenberg metric: 0.1476804926142453
FCF margin (%): -1.4022594399753836
Revenue growth (%): 21.795786670819975
Rule of 40 score: 20.39352723084459
Financial ratios for BA.TO — quarterly report dated 2025-09-30
Total revenue: 16741007194.244606
Gross profit: -1708633093.5251799
Operating income: -3448920863.309353
Net income: -3839568345.3237414
Capital expenditures: 635971223.0215827
Operating cash flow: 807913669.0647483
Depreciation & amortization: 353237410.07194245
Net tangible assets: -12248920863.309353
Owner earnings: -4122302158.2733817
Buffett classification: The Gruesome
Shares outstanding: 6214434086
Book value: -5937410071.942444
Debt to equity: -6.46467951048104
Current ratio: 1.1820293445859626
Quick ratio: 0.38429600092911625
Interest coverage ratio: -6.9077809798270895
COGS to revenue (%): 110.20627417275462
R&D to revenue (%): 3.8547486033519553
SG&A to revenue (%): 6.540610227761065
Free cash flow (dilution-adjusted): 107194244.60431656
Retained earnings: 6559712230.215828
Inventory turnover: 0.31113133151349714
Receivables turnover: 1.8848209946541388
Capitalized R&D asset: 1285129468.12679
ROCI (R&D-adjusted, %): -9.852929598528165
Rosenberg metric: -5.2481619100324135
FCF margin (%): 0.640309411259132
Revenue growth (%): 0.8184089679331461
Rule of 40 score: 1.4587183791922782
Financial ratios for BET.V — annual report dated 2022-06-30
Capital expenditures: 0
Net tangible assets: 203926.35658914727
Buffett classification: The Gruesome
Shares outstanding: 206764717
Book value: 203926.35658914727
Debt to equity: 0
Current ratio: 8.25656515502593
Quick ratio: 8.25656515502593
Retained earnings: -504553.488372093
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BET.V — annual report dated 2022-12-31
Total revenue: 4223550.735294118
Gross profit: 880229.4117647058
Operating income: -14748626.470588233
Net income: -14850761.029411763
Capital expenditures: 5619.117647058823
Operating cash flow: -9068902.205882352
Depreciation & amortization: 51511.76470588235
Net tangible assets: -12259809.558823528
Owner earnings: -14804868.38235294
Buffett classification: The Gruesome
Shares outstanding: 206764717
Book value: -11911525.735294117
Debt to equity: -0.756188009944644
Current ratio: 0.4882652880688474
Quick ratio: 0.4882652880688474
Interest coverage ratio: -144.40387896589706
COGS to revenue (%): 79.15901886985598
SG&A to revenue (%): 368.8210487795239
Free cash flow (dilution-adjusted): -9698014.705882352
Retained earnings: -16408468.38235294
Receivables turnover: 7.756761136446196
Capitalized R&D asset: 0
FCF margin (%): -229.6175733096055
Rule of 40 score: -229.6175733096055
Financial ratios for GCDT — annual report dated 2023-03-31
Operating income: -334977.5796178344
Net income: -636080.1273885351
Capital expenditures: 0
Operating cash flow: 465940
Net tangible assets: -1690637.8343949046
Owner earnings: -636080.1273885351
Buffett classification: The Gruesome
Shares outstanding: 12875000
Free cash flow (dilution-adjusted): 410375.41401273885
Retained earnings: -2986963.821656051
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GCDT — annual report dated 2024-03-31
Total revenue: 668765.7726692209
Gross profit: 184563.72924648787
Operating income: -722488.3780332056
Net income: -1011742.017879949
Capital expenditures: 0
Operating cash flow: 173602.68199233717
Depreciation & amortization: 511259.64240102173
Net tangible assets: -2071732.4393358876
Owner earnings: -500482.3754789272
Buffett classification: The Gruesome
Shares outstanding: 12875000
Book value: -2071732.4393358878
Debt to equity: -1.860014677901436
Current ratio: 0.10111325312613799
Quick ratio: 0.10111325312613799
Interest coverage ratio: -2.252003265893664
COGS to revenue (%): 72.40233624549217
SG&A to revenue (%): 126.56549225465565
Free cash flow (dilution-adjusted): 162623.37164750957
Retained earnings: -4006335.3767560665
Receivables turnover: 4.788513645121673
Capitalized R&D asset: 0
FCF margin (%): 24.316939995065347
Rule of 40 score: 24.316939995065347
Financial ratios for YMT — annual report dated 2022-12-31
Total revenue: 22384339.08045977
Gross profit: 15476724.137931034
Operating income: -11893247.126436781
Net income: -16627155.172413792
Capital expenditures: 193103.44827586206
Operating cash flow: -5195402.2988505745
Depreciation & amortization: 236350.5747126437
Net tangible assets: -180087356.3218391
Owner earnings: -16583908.045977011
Buffett classification: The Gruesome
Shares outstanding: 6711076
Book value: -180049281.60919538
Debt to equity: -0.3261000540241617
Current ratio: 0.09560609806345283
Quick ratio: 0.09560609806345283
Interest coverage ratio: -125.9923896499239
COGS to revenue (%): 30.859141820982707
R&D to revenue (%): 33.89325716486408
SG&A to revenue (%): 89.36872171764178
Free cash flow (dilution-adjusted): -5388505.747126437
Retained earnings: -202762500
Receivables turnover: 3.689289350919984
Capitalized R&D asset: 7586781.609195402
FCF margin (%): -24.072659584710678
Rule of 40 score: -24.072659584710678
Financial ratios for YMT — annual report dated 2023-12-31
Total revenue: 26374542.897327706
Gross profit: 19447960.618846692
Operating income: -14024472.573839663
Net income: -14853727.144866385
Capital expenditures: 291139.2405063291
Operating cash flow: -2525457.1026722924
Depreciation & amortization: 284247.53867791843
Net tangible assets: -193629957.80590716
Owner earnings: -14860618.846694795
Buffett classification: The Gruesome
Shares outstanding: 6711076
Book value: -193594233.4739803
Debt to equity: -0.19506122612072316
Current ratio: 0.11072206275363754
Quick ratio: 0.11072206275363754
Interest coverage ratio: -472.57819905213273
COGS to revenue (%): 26.262378481572927
R&D to revenue (%): 25.305162566725148
SG&A to revenue (%): 102.04561573780282
Free cash flow (dilution-adjusted): -10050914.205344584
Retained earnings: -223960478.19971868
Receivables turnover: 7.383376643830223
Capitalized R&D asset: 11757264.634560358
Rosenberg metric: 0.5234415178238956
FCF margin (%): -38.108392037243426
Revenue growth (%): 17.825872823518623
Rule of 40 score: -20.282519213724804
Financial ratios for YMT — annual report dated 2024-12-31
Total revenue: 22098767.12328767
Gross profit: 17910684.93150685
Operating income: -4661232.876712329
Net income: -4780821.917808219
Capital expenditures: 48082.19178082192
Operating cash flow: -8416301.369863015
Depreciation & amortization: 199178.08219178082
Net tangible assets: -202577123.28767124
Owner earnings: -4629726.02739726
Buffett classification: The Gruesome
Shares outstanding: 6711076
Book value: -198438356.16438356
Debt to equity: -0.19925169128814027
Current ratio: 0.09849436167860526
Quick ratio: 0.09799999165620216
Interest coverage ratio: -35.29771784232365
COGS to revenue (%): 18.951655395143842
R&D to revenue (%): 23.43836202354312
SG&A to revenue (%): 78.83784504187304
Free cash flow (dilution-adjusted): -8464383.561643835
Retained earnings: -235004931.50684932
Inventory turnover: 129
Receivables turnover: 10.298838100102143
Capitalized R&D asset: 12154888.012917995
Rosenberg metric: -0.230333806861237
FCF margin (%): -38.30251486167331
Revenue growth (%): -16.21175309344702
Rule of 40 score: -54.51426795512033
Financial ratios for YMT — quarterly report dated 2025-03-31
Total revenue: 4722038.567493113
Gross profit: 3736501.3774104686
Operating income: -380853.99449035816
Net income: -362947.6584022039
Capital expenditures: 78512.39669421488
Operating cash flow: -146005.50964187327
Depreciation & amortization: 48898.07162534435
Net tangible assets: -206454269.9724518
Owner earnings: -392561.98347107443
Buffett classification: The Gruesome
Shares outstanding: 6711076
Book value: -202329752.06611574
Debt to equity: -0.19963524072886496
Current ratio: 0.09363699010873933
Quick ratio: 0.09307486836982613
Interest coverage ratio: -19.75
COGS to revenue (%): 20.871011026194505
R&D to revenue (%): 18.11154541742022
SG&A to revenue (%): 71.0751998133131
Free cash flow (dilution-adjusted): -224517.90633608817
Retained earnings: -239794765.8402204
Inventory turnover: 26.500000000000004
Receivables turnover: 1.5733627059525448
Capitalized R&D asset: 855234.1597796143
FCF margin (%): -4.754681757190363
Rule of 40 score: -4.754681757190363
Financial ratios for YMT — quarterly report dated 2025-06-30
Total revenue: 4481589.958158996
Gross profit: 3658298.4658298464
Operating income: -1664574.6164574616
Net income: -1630822.8730822874
Capital expenditures: 0
Net tangible assets: -213146861.9246862
Owner earnings: -1630822.8730822874
Buffett classification: The Gruesome
Shares outstanding: 6711076
Book value: -209015760.111576
Debt to equity: -0.18740553954477485
Current ratio: 0.09245528097756821
Quick ratio: 0.09067181347698797
Interest coverage ratio: -143.7951807228916
COGS to revenue (%): 18.370522515793734
R&D to revenue (%): 26.13512588304858
SG&A to revenue (%): 103.48240126972273
Retained earnings: -247686471.40864715
Inventory turnover: 6.738584474885845
Receivables turnover: 8.108251324753976
Capitalized R&D asset: 1744276.0641792594
Rosenberg metric: -0.0914403507932545
Revenue growth (%): -5.0920509415019195
Rule of 40 score: -5.0920509415019195
Financial ratios for 3677.HK — annual report dated 2022-12-31
Total revenue: 472737500
Gross profit: -41706896.551724136
Operating income: -125773706.89655173
Net income: -247123706.89655173
Capital expenditures: 384406752.87356323
Operating cash flow: 194488793.10344827
Depreciation & amortization: 42241522.98850575
Net tangible assets: 276182183.908046
Owner earnings: -589288936.7816092
Return on net tangible assets (%): -213.36964189471797
Buffett classification: The Gruesome
Shares outstanding: 1485293739
Book value: 355253448.2758622
Debt to equity: 1.2662867371683801
Current ratio: 0.883376180211815
Quick ratio: 0.6918190513977209
Interest coverage ratio: -26.61391827800073
COGS to revenue (%): 108.82242186239172
R&D to revenue (%): 10.007649867654553
SG&A to revenue (%): 1.7849995121955669
Free cash flow (dilution-adjusted): -199560201.14942527
Retained earnings: -593283333.3333334
Inventory turnover: 3.5348625755242273
Receivables turnover: 4.742734372522508
Capitalized R&D asset: 47309913.79310345
ROCI (R&D-adjusted, %): -11.941633626302558
FCF margin (%): -42.21374465732574
Rule of 40 score: -42.21374465732574
Financial ratios for 3677.HK — annual report dated 2023-12-31
Total revenue: 585326300.9845288
Gross profit: 29323347.39803094
Operating income: -74796765.11954993
Net income: -82963009.84528832
Capital expenditures: 110314205.34458509
Operating cash flow: 39993530.23909986
Depreciation & amortization: 58207172.99578059
Net tangible assets: 598377496.4838256
Owner earnings: -135070042.1940928
Return on net tangible assets (%): -22.572714212648172
Buffett classification: The Gruesome
Shares outstanding: 1485293739
Book value: 667683966.2447257
Debt to equity: 0.787494736407503
Current ratio: 0.7081866261593892
Quick ratio: 0.6083889999456912
Interest coverage ratio: -7.2402690228860065
COGS to revenue (%): 94.99025631537341
R&D to revenue (%): 10.19059656339883
SG&A to revenue (%): 1.8850845934444587
Free cash flow (dilution-adjusted): -80636286.91983122
Retained earnings: -664056540.0843881
Inventory turnover: 6.440965139241001
Receivables turnover: 3.13318130452164
Capitalized R&D asset: 91345884.15417819
ROCI (R&D-adjusted, %): -4.185244093669895
Rosenberg metric: 1.5013818089034316
FCF margin (%): -13.776296534804539
Revenue growth (%): 23.81634648923108
Rule of 40 score: 10.040049954426541
Financial ratios for 3677.HK — annual report dated 2024-12-31
Total revenue: 702783150.6849315
Gross profit: 102526575.34246576
Operating income: -14597534.246575342
Net income: 12467671.232876712
Capital expenditures: 83735616.43835616
Operating cash flow: -49471506.84931507
Depreciation & amortization: 83416712.32876712
Net tangible assets: 749693972.6027397
Owner earnings: 12148767.123287678
Return on net tangible assets (%): 1.6204968383446334
Buffett classification: The Gruesome
Shares outstanding: 1485293739
Book value: 807824931.5068495
Debt to equity: 0.7106712392926582
Current ratio: 0.8823453083197405
Quick ratio: 0.7778747332676486
Effective tax rate (%): -15.144921118884657
Interest coverage ratio: -0.8037259116793
COGS to revenue (%): 85.41134982497182
R&D to revenue (%): 10.84075311525584
SG&A to revenue (%): 6.573239041564098
Free cash flow (dilution-adjusted): -143170410.95890412
Retained earnings: -352810684.9315069
Inventory turnover: 6.4561596081990595
Receivables turnover: 2.7579117071224983
Capitalized R&D asset: 131763579.93466924
ROCI (R&D-adjusted, %): 0.03926488299141201
Rosenberg metric: 1.2272487100533875
FCF margin (%): -20.371918538367122
Revenue growth (%): 20.06690106062863
Rule of 40 score: -0.30501747773849175